Target intelligence / Profile preview

U2 small nuclear RNA (U2 snRNA)

Target
U2 snRNA
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA, Major spliceosomal RNA, Component of small nuclear ribonucleoprotein (snRNP)
01

Overview

U2 small nuclear RNA is a highly conserved, non-coding RNA found in all eukaryotic cells, acting as a core catalytic RNA element within the major spliceosome[1][2]. It functions as part of the U2 small nuclear ribonucleoprotein (U2 snRNP) complex and is essential for pre-mRNA splicing; the U2 snRNA base pairs with the branch point sequence (BPS) of introns, positioning the branch adenosine for the first catalytic step of splicing, and forms critical RNA-RNA and RNA-protein contacts for spliceosome assembly and function[1][2][3]. U2 snRNA is heavily modified post-transcriptionally (including by pseudouridylation and 2′-O-methylation), and these modifications are vital for proper snRNP assembly and splicing function[4]. The dynamic rearrangement and RNA-protein interactions involving U2 snRNA are central to the conformational and catalytic activities of the spliceosome[7]. While not a direct therapeutic target like enzymes or receptors, disruption in U2 snRNA function or spliceosome assembly can cause global defects in gene expression and is implicated in disease through general splicing errors[1][2].

Other names
U2 spliceosomal RNAU2 snRNAU2 spliceosomal small nuclear RNALOC124904145
02

Biological functions

Pre-mRNA splicingRecognition of branch point in intronsAssembly and catalysis within the major spliceosome
03

Disease associations

Other (no direct established disease association, but faults in splicing machinery are implicated in various diseases)

Beyond the preview

Go deeper on U2 small nuclear RNA (U2 snRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U2 small nuclear RNA (U2 snRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call